Italy Formally Submits Detailed Opinion to EU Obstructing Ireland's Disposable Vape Ban

Apr.10
Italy's Ministry of Enterprises and Made in Italy has submitted a detailed opinion against Ireland's proposed "Public Health (Single Use Vapes) Bill 2025." Italy argued that the comprehensive ban on disposable vapes lacks scientific evidence, violates the EU principle of the free movement of goods, and conflicts with the existing Tobacco Products Directive.

Key Takeaways

  •  According to a European Commission document, the standstill period for Ireland's bill banning disposable vapes has been formally extended to June 19, 2026.
  • Italy's Ministry of Enterprises and Made in Italy submitted a detailed opinion to the EU on March 19, 2026, opposing Ireland's "Public Health (Single Use Vapes) Bill 2025."
  • The Irish bill intends to prohibit the retail sale of disposable vaping devices nationwide, regardless of whether they contain nicotine.
  • Italy pointed out that Ireland's total ban constitutes a quantitative restriction, violating the Treaty on the Functioning of the European Union (TFEU) principle of free movement of goods.

 

2Firsts, April 10, 2026 

 

According to the European Commission, the EU's Technical Regulations Information System published a detailed opinion from Italy regarding Ireland's "Public Health (Single Use Vapes) Bill 2025." The bill originally planned to completely ban the retail sale of disposable vapes in Ireland.

 

Ban standstill period extended to June 2026

 

Under EU Directive 2015/1535, due to the submission of this detailed opinion by Italy, the standstill period for the Irish bill has been formally extended to June 19, 2026. During this period, Ireland may not adopt or implement the legislation.

 

Ireland notified the EU of the draft on December 18, 2025. The draft plans to completely ban the retail sale of any non-reusable vaping device, regardless of whether it contains nicotine. 

 

Italy's Ministry of Enterprises and Made in Italy submitted the formal objection to the European Commission on March 19, 2026.

 

Italy alleges ban violates EU principle of free movement of goods

 

In its detailed opinion, Italy explicitly stated that the Irish bill lacks scientific evidence and exceeds the existing EU regulatory framework. 

 

The ban constitutes a quantitative restriction under Article 34 of the Treaty on the Functioning of the European Union (TFEU), preventing products legally manufactured and sold in other EU member states from entering the Irish market, thereby violating the core principle of the free movement of goods.

 

At the same time, Italy argued that the measure is incompatible with Article 24 of the EU Tobacco Products Directive (2014/40/EU - TPD). 

 

The provision stipulates that member states can only ban specific categories of products under exceptional circumstances justified by the need to protect public health. Italy pointed out that Ireland failed to provide appropriate documentation proving the existence of such exceptional circumstances.

 

Lack of proportionality and alternative considerations

 

In its analysis of proportionality, Italy emphasised that Ireland's comprehensive ban failed to adequately assess less restrictive alternatives before restricting trade. 

 

For example, Ireland could have adopted stricter age control measures, targeted information campaigns, or differentiated taxation tools, rather than directly implementing a sales ban.

 

Furthermore, the ban was cited as undermining the "freedom of establishment" (Article 49 of TFEU) of legitimate EU operators already present or intending to operate in Ireland, raising risks of unequal treatment in market access and the fragmentation of EU regulations.

 

Image Source: European Commission

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Product | JT to Launch MEVIUS Tropical Option in Japan, Expanding Ploom Tobacco Stick Lineup to 32
Product | JT to Launch MEVIUS Tropical Option in Japan, Expanding Ploom Tobacco Stick Lineup to 32
Japan Tobacco (JT) will launch MEVIUS Tropical Option, a new tobacco stick for Ploom, nationwide in Japan from October 6, 2026. The capsule-format product combines mango-oriented sweetness with menthol cooling, adding a tropical flavor to the MEVIUS Ploom tobacco-stick lineup for the first time. Each pack contains 20 sticks and will launch at JPY 590. The product is compatible with all Ploom devices, and its addition will expand the Ploom tobacco-stick portfolio to 32 variants.
Sep.08
Kelly White Bets on Female Consumers as Nicotine Pouch Competition Intensifies | 2Firsts Interview
Kelly White Bets on Female Consumers as Nicotine Pouch Competition Intensifies | 2Firsts Interview
Swedish nicotine pouch brand Kelly White is building its strategy around adult female consumers. Founder and CEO Sophia Wilsby told 2Firsts that women accounted for around 70% of the brand’s repeat customers on HAYPP in Sweden in 2025. The interview explores female consumer segmentation, product and design differentiation, gender stereotypes, packaging regulation, and how independent brands can compete with global players such as ZYN and VELO while considering funding, partnerships and future ownership options.
Business
Sep.24
Earnings Analysis | CTIHK H1 2026 Revenue Falls 26.9% as Core Businesses Diverge and New Growth Drivers Remain to Be Proven
Earnings Analysis | CTIHK H1 2026 Revenue Falls 26.9% as Core Businesses Diverge and New Growth Drivers Remain to Be Proven
China Tobacco International (HK) reported a 26.9% revenue decline in H1 2026, while gross profit fell only 9.5%, revealing sharp divergence across its businesses. Tobacco leaf imports contracted, while leaf exports and Brazil operations expanded strongly. Cigarette exports faced China duty-free market transition, and new tobacco products remained small. Meanwhile, CTIHK continues to strengthen its role as an investment and financing platform, though major external deals have yet to emerge. 2Firsts examines what these shifts mean for its next growth drivers.
Capital Markets
Aug.24
Ispire Q4 Revenue Rebounds 33% but Full-Year Sales Still Fall 25% as FY2027 Focus Shifts to Malaysia Manufacturing, ODM, Nicotine Pouches and Age Verification
Ispire Q4 Revenue Rebounds 33% but Full-Year Sales Still Fall 25% as FY2027 Focus Shifts to Malaysia Manufacturing, ODM, Nicotine Pouches and Age Verification
Ispire Technology reported FY2026 revenue of about $96 million, down 24.7% year over year, as U.S. cannabis-vapor hardware and European e-cigarette sales declined by $17.4 million and $12.7 million, respectively. Fourth-quarter revenue rose 32.5% to $26.7 million, while quarterly gross margin fell to 6.3%. For FY2027, the company is prioritizing Malaysia manufacturing and vapor ODM while continuing to develop nicotine pouches, IKE Tech age-verification technology and G-Mesh licensing. Ispire has not separately disclosed the revenue or profit contribution of those newer businesses.
Regulations
Sep.17 by 2Firsts Perspectives
Australia Extends Illicit Tobacco Crackdown From Tougher Penalties to Customs and Logistics Supply Chains
Australia Extends Illicit Tobacco Crackdown From Tougher Penalties to Customs and Logistics Supply Chains
Australia's federal government introduced a new illicit tobacco enforcement bill on September 10 that would strengthen evidentiary presumptions, representative sampling, seizure and forfeiture procedures, proceeds-of-crime powers and obligations for customs and logistics operators. The proposal follows the Combatting Illicit Tobacco Act 2026, which took effect in August and increased penalties while expanding investigative and asset-recovery tools. Together, the reforms extend Australia's crackdown from tougher criminal sanctions into import, logistics and evidentiary enforcement.
Sep.14
UK ONS Data: Vaping Rate Among Women Aged 25–34 Reaches 18.3%, Compared With 14.4% for Men
UK ONS Data: Vaping Rate Among Women Aged 25–34 Reaches 18.3%, Compared With 14.4% for Men
The vaping rate among women aged 25 to 34 in Great Britain reached 18.3% in 2025, up from 13.7% in 2024 and 8.3% in 2020, according to data from the Office for National Statistics (ONS). The figure was the highest for this group since records began in 2014 and exceeded the 14.4% recorded among men of the same age. Adults aged 25 to 34 also overtook those aged 16 to 24 as the age group with the highest vaping prevalence. Overall, about 5.4 million adults in Great Britain used e-cigarettes in 2025, broadly unchanged from the previous year.
DATA
Oct.13